TRIGGERING CD28 MOLECULES SYNERGIZE WITH CD2 (T11.1 AND T11.2)-MEDIATED T-CELL ACTIVATION

被引:80
|
作者
PIERRES, A
LOPEZ, M
CERDAN, C
NUNES, J
OLIVE, D
MAWAS, C
机构
关键词
D O I
10.1002/eji.1830180505
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:685 / 690
页数:6
相关论文
共 50 条
  • [1] REGULATION OF T-CELL DIFFERENTIATION BY CD2 AND CD28 ACCESSORY MOLECULES
    DEJONG, R
    STOKKERS, P
    LAMME, E
    KOOL, JM
    BORST, F
    BROUWER, M
    MIEDEMA, F
    VANLIER, RAW
    [J]. IMMUNOLOGY, 1991, 74 (02) : 175 - 182
  • [2] Coordinate regulation of T cell activation by CD2 and CD28
    Green, JM
    Karpitskiy, V
    Kimzey, SL
    Shaw, AS
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (07): : 3591 - 3595
  • [3] ENHANCED LAMINA PROPRIA T-CELL ACTIVATION - ROLE OF CD3, CD2, AND CD28 MOLECULES
    TARGAN, SR
    DEEM, RL
    NEL, A
    [J]. FASEB JOURNAL, 1991, 5 (05): : A982 - A982
  • [4] CD28 AND T-CELL ACTIVATION
    OLIVE, D
    VANLIER, R
    [J]. RESEARCH IN IMMUNOLOGY, 1995, 146 (03): : 127 - 129
  • [5] CD28 AND T-CELL ACTIVATION - DISCUSSION
    LEDBETTER, J
    LINSLEY, P
    LANE, P
    RUDD, CE
    SCHNEIDER, H
    SOMOZA, C
    LANIER, LL
    VANGOOL, SW
    CEUPPENS, JL
    DEBOER, M
    CHIODETTI, L
    SCHWARTZ, RH
    [J]. RESEARCH IN IMMUNOLOGY, 1995, 146 (03): : 197 - 205
  • [6] INDUCTION OF LYSIS BY T-CELL RECEPTOR GAMMA-DELTA+/CD3+ LYMPHOCYTES-T VIA CD2 REQUIRES TRIGGERING VIA THE T11.1 EPITOPE ONLY
    GOEDEGEBUURE, PS
    SEGAL, DM
    BRAAKMAN, E
    VREUGDENHIL, RJ
    VANKRIMPEN, BA
    VANDEGRIEND, RJ
    BOLHUIS, RLH
    [J]. JOURNAL OF IMMUNOLOGY, 1989, 142 (06): : 1797 - 1802
  • [7] TRIGGERING T-CELL ACTIVATION THROUGH THE CD2 DEFINED MOLECULE
    BERNARD, A
    BROTTIER, P
    GELIN, C
    TRAN, HC
    RAYNAL, B
    BOUMSELL, L
    [J]. FEDERATION PROCEEDINGS, 1985, 44 (04) : 1298 - 1298
  • [8] ROLE OF THE CD28 RECEPTOR IN T-CELL ACTIVATION
    JUNE, CH
    LEDBETTER, JA
    LINSLEY, PS
    THOMPSON, CB
    [J]. IMMUNOLOGY TODAY, 1990, 11 (06): : 211 - 216
  • [9] The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
    Riley, JL
    June, CH
    [J]. BLOOD, 2005, 105 (01) : 13 - 21
  • [10] T-CELL ACTIVATION - THE T-CELL ERYTHROCYTE RECEPTOR (CD2) AND SIALOPHORIN (CD43)
    BIERER, BE
    PETERSON, A
    PARK, J
    REMOLDODONNELL, E
    ROSEN, FS
    SEED, B
    BURAKOFF, SJ
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1988, 8 (01) : 51 - 67